Schedule 13G ownership disclosure
Celladon Corp
Security class unavailable · CUSIP: 15117E107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 217
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000790502-15-000049
- Form type
- SC 13G
- Filer
- Eiger BioPharmaceuticals, Inc.
- CIK
- CIK 1305253
- Filed
- May 11, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership